Ratna K. Vadlamudi
0000-0003-2849-4076
Publication & Citation Trends
Most Cited Works
Publications
566 total
Targeting LIPA with ERX-41 Induces ER Stress and Inhibits Tumor Progression in Inflammatory Breast Cancer
Cited by 0
Semantic Scholar
Abstract 3110: Targeting LIF/LIFR signaling with EC359 overcomes chemoresistance and enhances chemotherapy efficacy in ovarian cancer
Cited by 0
Semantic Scholar
Abstract 5679: LIFR inhibition with EC359 triggers ferroptosis to overcome chemoresistance in endometrial cancer.
Cited by 0
Semantic Scholar
Abstract 1260: LIPA inhibition enhances the therapeutic efficacy of DNA-damaging agents in ovarian cancer through induction of ER stress and enhancing DNA damage.
Cited by 0
Semantic Scholar
Abstract 3796: Targeting midkine with HBS-101 enhances chemotherapy and immunotherapy response in TNBC via immune activation and oncogenic pathway suppression
Cited by 0
Semantic Scholar
Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer
Cited by 0
Semantic Scholar
Midkine (MDK) as a Central Regulator of the Tumor Microenvironment: From Developmental Cytokine to Therapeutic Target.
Cited by 1
Semantic Scholar
Abstract 461: Next-generation ERβ agonists with superior brain uptake suppress glioblastoma and enhance temozolomide response.
Cited by 0
Semantic Scholar
Research Topics
Estrogen and related hormone effects
(180)
Cancer, Lipids, and Metabolism
(51)
Cytokine Signaling Pathways and Interactions
(47)
Epigenetics and DNA Methylation
(44)
Cancer-related Molecular Pathways
(43)
Frequent Co-Authors
Affiliations
Universidad Mayor
The Graduate Center, CUNY
University of Wyoming
Fox Chase Cancer Center
Texas A&M University – San Antonio